002550.SZ
Changzhou Qianhong Biopharma Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 6.50
−3.42%Margins
Gross margin
60.2%
EBITDA margin
35.5%
EBIT margin
25.1%
Net margin
21.8%
FCF margin
17.7%
11.3%
Return on equity
10.0%
Return on assets
13.0%
Return on invested capital
0.47x
Asset turnover
CNY 428.1M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026